For patients with a family history of self-limited familial infantile epilepsy, PKD or ICCA, the PRRT2 gene could be detected by sanger sequencing and used as a biomarker for the selection of anticonvulsants. The gene discussed is PRRT2; the disease is infantile convulsions and choreoathetosis.